Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiajun Du

Showing results (151-160 of 193) with videos related to

Pageof 20
Sort By:
Journal of Cancer|May 4, 2018
Survival Outcomes for Patients with Surgical and Non-Surgical Treatments in Stages I-III Small-Cell Lung CancerKeying Che, Hongchang Shen, Xiao Qu, et al.
Journal of Cancer Research and Clinical Oncology|May 6, 2018
Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinomaKai Wang, Xiao Qu, Shaorui Liu, et al.
Oncogene|April 23, 2024
ZBTB16 inhibits DNA replication and induces cell cycle arrest by targeting WDHD1 transcription in lung adenocarcinomaKai Wang, Deyu Guo, Tao Yan, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 6, 2023
Defective Nb<sub>2</sub>C MXene Cocatalyst on TiO<sub>2</sub> Microsphere for Enhanced Photocatalytic CO<sub>2</sub> Conversion to MethaneLei Yang, Jiajun Du, Jun Deng, et al.
Frontiers in Oncology|December 19, 2022
Distinct gene mutation profiles among multiple and single primary lung adenocarcinomaYadong Wang, Guanghui Wang, Haotian Zheng, et al.
International Journal of Surgery (London, England)|November 29, 2016
Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderlyChen Qiu, Guanghui Wang, Jun Xu, et al.
Clinical Drug Investigation|November 19, 2016
Adverse Events and Efficacy of Cixutumumab in Phase II Clinical Trials: A systematic Review and Meta-AnalysisHongxin Cao, Lixuan Cui, Wei Ma, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2012
High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancerMiaomiao Yang, Hongchang Shen, Chen Qiu, et al.
Aging|May 21, 2024
Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analysesYong Liu, Xiangwei Zhang, Zhaofei Pang, et al.
Journal of Cancer Research and Therapeutics|July 5, 2018
Comparison of the short-term clinical outcome between open and minimally invasive esophagectomy by comprehensive complication indexGuoyuan Ma, Hongxin Cao, Ran Wei, et al.
Pageof 20

Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
Journal of Cancer|May 4, 2018
Survival Outcomes for Patients with Surgical and Non-Surgical Treatments in Stages I-III Small-Cell Lung CancerKeying Che, Hongchang Shen, Xiao Qu, et al.
Journal of Cancer Research and Clinical Oncology|May 6, 2018
Identification of aberrantly expressed F-box proteins in squamous-cell lung carcinomaKai Wang, Xiao Qu, Shaorui Liu, et al.
Oncogene|April 23, 2024
ZBTB16 inhibits DNA replication and induces cell cycle arrest by targeting WDHD1 transcription in lung adenocarcinomaKai Wang, Deyu Guo, Tao Yan, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 6, 2023
Defective Nb<sub>2</sub>C MXene Cocatalyst on TiO<sub>2</sub> Microsphere for Enhanced Photocatalytic CO<sub>2</sub> Conversion to MethaneLei Yang, Jiajun Du, Jun Deng, et al.
Frontiers in Oncology|December 19, 2022
Distinct gene mutation profiles among multiple and single primary lung adenocarcinomaYadong Wang, Guanghui Wang, Haotian Zheng, et al.
International Journal of Surgery (London, England)|November 29, 2016
Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderlyChen Qiu, Guanghui Wang, Jun Xu, et al.
Clinical Drug Investigation|November 19, 2016
Adverse Events and Efficacy of Cixutumumab in Phase II Clinical Trials: A systematic Review and Meta-AnalysisHongxin Cao, Lixuan Cui, Wei Ma, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2012
High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancerMiaomiao Yang, Hongchang Shen, Chen Qiu, et al.
Aging|May 21, 2024
Prediction of prognosis and immunotherapy efficacy based on metabolic landscape in lung adenocarcinoma by bulk, single-cell RNA sequencing and Mendelian randomization analysesYong Liu, Xiangwei Zhang, Zhaofei Pang, et al.
Journal of Cancer Research and Therapeutics|July 5, 2018
Comparison of the short-term clinical outcome between open and minimally invasive esophagectomy by comprehensive complication indexGuoyuan Ma, Hongxin Cao, Ran Wei, et al.
Pageof 20